Pulsenmore

Pulsenmore EV/EBIT

The EV/EBIT (Enterprise Value to EBIT) of Pulsenmore (PLSM.TA) as of Nov 17, 2026 is -8.91. In the previous year, EV/EBIT (Enterprise Value to EBIT) was -2.57 — a change of 246.26% (lower).

EV/EBIT

-8.91

YoY

246.26%

Last updated:

EV/EBIT (Enterprise Value to EBIT) of Pulsenmore is 2025 -8.91 . EV/EBIT (Enterprise Value to EBIT) of Pulsenmore was 2024 -2.57 . It decreases by 246.26% lower compared to the previous year.

The Pulsenmore EV/EBIT history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/EBIT
Date
EV/EBIT
Jan 1, 2019
-25.89 ILS
Jan 1, 2020
-8.16 ILS
Jan 1, 2021
-4.25 ILS
Jan 1, 2022
-2.39 ILS
Jan 1, 2023
-1.97 ILS
Jan 1, 2024
-2.57 ILS
Jan 1, 2025
-8.91 ILS
The Pulsenmore EV/EBIT history
YEAREV/EBITYoY
-8.91+246.26%
-2.57+30.85%
-1.97-17.89%
-2.39-43.61%
-4.25-47.95%
-8.16-68.50%
-25.89—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Pulsenmore Valuation

Details

Historical Valuation Multiples

ⓘ

Price-to-Earnings Ratio (P/E)

The P/E ratio divides Pulsenmore's share price by its earnings per share. It tells you how many years of current earnings you are "paying for" when you buy the stock. A P/E of 20 means you pay $20 for every $1 of annual earnings. The S&P 500 historically trades at an average P/E of roughly 15–17. A P/E significantly above that may signal high growth expectations; one below may indicate undervaluation — or declining business quality.

Price-to-Sales Ratio (P/S)

The P/S ratio divides market capitalization by total revenue. Unlike the P/E ratio, it works even for companies that are not yet profitable, making it essential for evaluating high-growth firms. A P/S below 1.0 may indicate undervaluation, while ratios above 10 are typically reserved for fast-growing tech or SaaS companies with high expected future margins.

Price-to-EBIT Ratio

This ratio relates Pulsenmore's market price to its operating earnings, excluding the effects of debt structure and tax jurisdiction. It is particularly useful for comparing companies across different countries or with different levels of leverage, because it focuses purely on operational profitability. Lower values suggest cheaper operational earnings.

How to Use This Chart

This chart plots Pulsenmore's valuation multiples over time. Compare the current P/E, P/S, and P/EBIT to their own historical averages — if the current ratio is well below the multi-year average, the stock may be relatively cheap compared to its own track record. Combine this with industry comparisons: a P/E that looks high in absolute terms may be justified if Pulsenmore grows earnings faster than its peers.

Pulsenmore Stock analysis

What does Pulsenmore do? Pulsenmore Ltd. generates revenue through the sale of its two miniaturized ultrasound systems, PulseNmore ES and PulseNmore FC, designed for home use in remote clinical diagnosis. The PulseNmore ES targets pregnant women requiring regular ultrasound monitoring, while PulseNmore FC caters to women undergoing in vitro fertilization needing follicle size assessments. Both systems integrate with smartphones, enabling patients to conduct tests at home and share results online with healthcare providers. The company also monetizes through software delivery for its devices, enhancing user experience and data management. The primary buyers of PulseNmore ES are pregnant women seeking convenient, clinic-free monitoring, and healthcare providers managing prenatal care remotely. PulseNmore FC is purchased by women undergoing in vitro fertilization, often through fertility clinics or medical centers that recommend the device. These segments value the convenience of home-based diagnostics and seamless telehealth integration without requiring in-person visits. Pulsenmore Ltd. focuses on global markets for its portable ultrasound solutions, serving patients in remote or underserved areas who benefit from telehealth-enabled diagnostics. The company’s products are positioned as cost-effective alternatives to traditional clinic visits, appealing to both end-users and healthcare institutions aiming to reduce operational costs while maintaining patient care quality. Pulsenmore is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Pulsenmore stock

EV/EBIT (Enterprise Value to EBIT) of Pulsenmore is -8.91 in 2025.

EV/EBIT (Enterprise Value to EBIT) of Pulsenmore changed from -2.57 to -8.91, representing a 246.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EV/EBIT (Enterprise Value to EBIT) Pulsenmore since 2006 – with annual values, charts, and detailed analysis.

The EV/EBIT ratio measures a company's enterprise value relative to its operating earnings. It accounts for debt, making it useful for comparing companies with different capital structures.

EV/EBIT = Enterprise Value / Earnings Before Interest and Taxes

To evaluate EV/EBIT (Enterprise Value to EBIT)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/EBIT (Enterprise Value to EBIT).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/EBIT (Enterprise Value to EBIT)'s Pulsenmore with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Pulsenmore

All Key Metrics — Pulsenmore